# SLIM: Combined Effects of Slo-Niacin and Atorvastatin on Lipoproteins and Inflammatory Markers in Hyperlipidemia

> **NCT00194402** · PHASE4 · COMPLETED · sponsor: **University of Washington** · enrollment: 64 (actual)

## Conditions studied

- Dyslipidemia

## Interventions

- **DRUG:** Slo-Niacin, atorvastatin

## Key facts

- **NCT ID:** NCT00194402
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-08
- **Primary completion:** 2006-01
- **Final completion:** 2006-01
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2008-08-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00194402

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00194402, "SLIM: Combined Effects of Slo-Niacin and Atorvastatin on Lipoproteins and Inflammatory Markers in Hyperlipidemia". Retrieved via AI Analytics 2026-08-13 from https://api.ai-analytics.org/clinical/NCT00194402. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*